Korean J Hematol.  1997 Aug;32(2):256-265.

The Expression of Fas Antigen and Apoptosis in Patients with Myelodysplastic Syndromes and Its Clinical Relevance

Affiliations
  • 1Department of Internal Medicine, Soonchunhyang University College of Medicine, Korea.
  • 2Department of Pediatrics, Soonchunhyang University College of Medicine, Korea.
  • 3Department of Clinical Pathology, Soonchunhyang University College of Medicine, Korea.
  • 4Institute for Clinical Molecular Biology Research, Soonchunhyang University College of Medicine, Korea.

Abstract

BACKGROUND: The myelodysplastic syndromes (MDS) are a group of acquired clonal hematopoietic disorders characterized by the peripheral cytopenias and hypercellular or normocellular dysplastic bone marrow. The event responsible for the development of MDS is generally not known. Several recent reports have described an increased frequency of apoptosis in bone marrow cells from patients with aplastic anemia or MDS. Gersuk et al observed that Fas ligand expression was significantly increased on bone marrow cells from MDS patients as compared to normal individuals.
METHODS
We examined apoptosis and Fas antigen expression using ISNEL method and immunohistochemistry on marrow cells from 36 patients with MDS.
RESULTS
Among the 36 patients, 15 patients (42%) demonstrated apoptosis positive cells (>15%) and 9 patients (25%) demonstrated positive Fas antigen expression (>20%). The presence of apoptosis significantly correlated with hemoglobin level at diagnosis (P<0.05) and the expression of Fas antigen significantly correlated with bone marrow cellularity and CD34 positive cell aggregate group at diagnosis (P<0.05). There was no statistically significant relationship between apoptosis and Fas antigen expression. The median survival of all patients with MDS was 44 months (2-117+). Multivariate analysis showed that FAB classification and hemoglobin level at diagnosis were significant prognostic factor but presence of apoptosis and expression of Fas antigen had no significance.
CONCLUSION
The data indicate that the apoptosis and expression of Fas antigen are present in patients with MDS and correlate with some clinical parameters but not significantly associated with survival period of the patients with MDS.

Keyword

Myelodysplastic syndrome; Apoptosis; Fas antigen; Prognostic factor

MeSH Terms

Anemia, Aplastic
Antigens, CD95*
Apoptosis*
Bone Marrow
Bone Marrow Cells
Classification
Diagnosis
Fas Ligand Protein
Humans
Immunohistochemistry
Multivariate Analysis
Myelodysplastic Syndromes*
Antigens, CD95
Fas Ligand Protein
Full Text Links
  • KJH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr